By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Eurofins Scientific SE

Eurofins Scientific SE (ESF.VI)

VIE Currency in EUR
€60.10
-€0.24
-0.40%
Last Update: 8 Jul 2025, 07:05
€10.58B
Market Cap
0.00
P/E Ratio (TTM)
0.87%
Forward Dividend Yield
€44.67 - €61.40
52 Week Range

ESF.VI Stock Price Chart

Explore Eurofins Scientific SE interactive price chart. Choose custom timeframes to analyze ESF.VI price movements and trends.

There is nothing to show.

ESF.VI Company Profile

Discover essential business fundamentals and corporate details for Eurofins Scientific SE (ESF.VI) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

IPO Date

21 Sept 2020

Employees

62.70K

CEO

Gilles G. Martin

Description

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 130,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; and testing for persistent organic pollutants, dioxins and organic contaminants, pesticides, mycotoxins, allergens, and pathogens and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

ESF.VI Financial Timeline

Browse a chronological timeline of Eurofins Scientific SE corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 28 Jan 2026

Upcoming earnings on 24 Jul 2025

Dividend declared on 28 Apr 2025

A dividend of €0.52 per share was announced, adjusted to €0.52. The dividend was paid on 30 Apr 2025.

Earnings released on 23 Apr 2025

Earnings released on 30 Jan 2025

EPS came in at €0.96 falling short of the estimated €1.49 by -35.64%, while revenue for the quarter reached €3.53B, beating expectations by +100.96%.

Earnings released on 22 Oct 2024

Earnings released on 24 Jul 2024

EPS came in at €1.13 falling short of the estimated €1.48 by -23.65%, while revenue for the quarter reached €3.42B, missing expectations by -1.48%.

Dividend declared on 3 Jul 2024

A dividend of €0.50 per share was announced, adjusted to €0.50. The dividend was paid on 5 Jul 2024.

Earnings released on 24 Apr 2024

Earnings released on 27 Feb 2024

EPS came in at €0.86 falling short of the estimated €1.20 by -28.33%, while revenue for the quarter reached €3.31B, missing expectations by -1.06%.

Earnings released on 31 Dec 2023

EPS came in at €0.80, while revenue for the quarter reached €3.31B.

Earnings released on 26 Jul 2023

EPS came in at €1.36 surpassing the estimated €1.27 by +7.09%, while revenue for the quarter reached €3.21B, missing expectations by -0.06%.

Dividend declared on 4 Jul 2023

A dividend of €1.00 per share was announced, adjusted to €1.00. The dividend was paid on 6 Jul 2023.

Earnings released on 30 Jun 2023

EPS came in at €0.76, while revenue for the quarter reached €3.21B.

Earnings released on 1 Mar 2023

EPS came in at €1.36 falling short of the estimated €1.49 by -8.72%, while revenue for the quarter reached €3.30B, missing expectations by -1.91%.

Earnings released on 31 Dec 2022

EPS came in at €1.52, while revenue for the quarter reached €3.30B.

Earnings released on 27 Jul 2022

EPS came in at €2.07 surpassing the estimated €1.96 by +5.61%, while revenue for the quarter reached €3.41B, beating expectations by 0.00%.

Dividend declared on 5 Jul 2022

A dividend of €1.00 per share was announced, adjusted to €1.00. The dividend was paid on 7 Jul 2022.

Earnings released on 30 Jun 2022

EPS came in at €1.55, while revenue for the quarter reached €3.41B.

Earnings released on 22 Feb 2022

EPS came in at €1.77 falling short of the estimated €2.22 by -20.27%, while revenue for the quarter reached €3.45B, beating expectations by +1.34%.

Earnings released on 31 Dec 2021

EPS came in at €1.83, while revenue for the quarter reached €3.45B.

Earnings released on 5 Aug 2021

EPS came in at €3.05 surpassing the estimated €2.36 by +29.24%, while revenue for the quarter reached €3.27B, beating expectations by +0.81%.

Dividend declared on 1 Jul 2021

A dividend of €0.68 per share was announced, adjusted to €0.68. The dividend was paid on 5 Jul 2021.

Earnings released on 30 Jun 2021

EPS came in at €2.07, while revenue for the quarter reached €3.27B.

Earnings released on 1 Mar 2021

EPS came in at -€4.40 surpassing the estimated -€4.71 by +6.58%, while revenue for the quarter reached €3.12B, beating expectations by +0.11%.

Earnings released on 31 Dec 2020

EPS came in at €2.26, while revenue for the quarter reached €3.12B.

Stock split effective on 19 Nov 2020

Shares were split 10:1, changing the number of shares outstanding and the price per share accordingly.

Earnings released on 6 Aug 2020

EPS came in at €1.03 surpassing the estimated €0.77 by +34.46%, while revenue for the quarter reached €2.32B, beating expectations by +0.92%.

ESF.VI Stock Performance

Access detailed ESF.VI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
ESF.VI
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
ESF.VI
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More